Pemetrexed Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-543

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pemetrexed (NDC 68001-543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This appears to be a graph for "Survival Probability" with "Survival Time (months)" on the x-axis and "3 s H 2 1 w2 oz 0 " on the y-axis. The values on the x-axis are 862, 737, 598, 458, 341, 285, 146, 88, 45, 10, and 0 for both lines plotted. However, the values on the y-axis are not interpretable and appear to be incorrectly recognized characters from the . Therefore, a useful description is not available.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
The text appears to be a list of medical product names and patient IDs along with some numerical values such as survival time measured in months. It is unclear what purpose or context this information serves without additional information.*
FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
This appears to be a section of a graph or chart displaying survival probability and survival time in months. It is not possible to provide further context or information without seeing the full image or data.*
FDA Label Image

Figure6 (Figure6)

Figure6 (Figure6)
This is a chart showing the survival probability of patients treated with Pometocea and a placebo. The patients at risk are also listed. The chart tracks survival time in months. The text is partially readable, but some characters are not recognizable.*
FDA Label Image

Figure7 (Figure7)

Figure7 (Figure7)
Patients at Risk who received Pemeterea 116 had a higher exposure than those who received Placsbo 66. Further information about the patients and the study is not available.*
FDA Label Image

Figure8 (Figure8)

Figure8 (Figure8)
This data appears to be from a clinical trial, displaying the survival probability of patients receiving either Pematrexed or a placebo. The number of patients at risk for each treatment is also provided. However, without more context or information, it is difficult to interpret the data fully.*
FDA Label Image

Figure9 (Figure9)

FDA Label Image

Carton 100mg (Pemetrexed 100mg Carton)

Carton 100mg (Pemetrexed 100mg Carton)
This is a pharmaceutical label providing information on Pemetrexed for intravenous use only. It includes a 2D code with encoded data, GTIN, S/N, EXP, and LOT numbers. There are also variable data which shall print online with -B font, with a non-varnish area of 40mm x 35mm. The label contains the drug name, dosage, cautionary statement, instructions for reconstitution, administration and storage conditions, and the manufacturer's information. The label also includes a code for inventory purposes, the volume of medication, the manufacturing date, and the recommended dosage.*
FDA Label Image

Carton 500mg (Pemetrexed 500mg Carton)

Carton 500mg (Pemetrexed 500mg Carton)
This is a label for Pemetrexed Pemelrexed, a medication for injection, containing 500 mg pemetrexed disodium equivalent. The label includes important information about the drug such as storage temperature, dosage and administration, serial number, and manufacturing information. It also features a 2D code encoded with human-readable data. The dimensions of the label are 55mm x 45mm, and there is a non-varnish area for batch and variable data.*
FDA Label Image

Label 100mg (Pemetrexed Vial 100mg)

FDA Label Image

Label 500mg (Pemetrexed Vial 500mg)

Label 500mg (Pemetrexed Vial 500mg)
Pemetrexed is an intravenous cytotoxic agent provided in a single-dose vial of 500 mg. It contains pemetrexed disodium, along with mannitol, in a hydrochloric acid or sodium hydroxide solution, which may be added to adjust pH levels. It should be stored at controlled room temperature and only administered intravenously. The accompanying literature will provide instructions on storing reconstituted and infusion solutions. Manufactured by Gland Pharma Limited in India, it is available from BluePoint Laboratories.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.